High pretreatment serum CA19-9 level predicts a poor prognosis for patients with stage III colon cancer after curative resection and adjuvant chemotherapy

Carbohydrate antigen 19-9 (CA19-9) is one of the most widely used tumor markers in gastrointestinal cancer. However, serum CA19-9 is not a recommended routine measurement in colon cancer. In this study, we evaluated the value of the preoperative serum CA19-9 level for the prediction of postoperative...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Wenhao, Yang, Fan, Peng, Jianhong, Wang, Fulong, Lin, Yuzhu, Jiang, Wu, Yang, Xia, Li, Liren, Lu, Zhenhai, Wan, Desen, Pan, Zhizhong, Fan, Wenhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636281/
https://www.ncbi.nlm.nih.gov/pubmed/31333798
http://dx.doi.org/10.7150/jca.31375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636281/
https://www.ncbi.nlm.nih.gov/pubmed/31333798
http://dx.doi.org/10.7150/jca.31375

Ejemplares similares